| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038264 Fractal dimension analysis of nanoparticle aggregates using angle dependent light scattering for the detection and characterization of nucleic acids and proteins |
| 02/26/2004 | US20040038263 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/26/2004 | US20040038261 Comprises base pairing, then imaging labelled single-stranded DNA using transmission electron microscopy |
| 02/26/2004 | US20040038260 Nanopump device for analyzing DNA sequences |
| 02/26/2004 | US20040038259 Method of producing a temporally spaced subtracted (TSS) cDNA library and uses thereof |
| 02/26/2004 | US20040038258 Methods for detecting DNA polymorphisms |
| 02/26/2004 | US20040038256 Using fluorescent nucleotides to identify genetic position of restriction fragment length polymorphism associated with drug resistance in microorganism |
| 02/26/2004 | US20040038255 Silver-gold shelled composite oligonucleotide conjugate for detecting target nucleic acids, peptides and proteins; colorimetric based DNA detection |
| 02/26/2004 | US20040038254 Compositions and methods for detecting nucleic acid methylation |
| 02/26/2004 | US20040038253 Method of synthesizing polynucleotide |
| 02/26/2004 | US20040038252 Method of testing for allergic diseases |
| 02/26/2004 | US20040038249 Inducible expression systems employing PPAR transcriptional activators |
| 02/26/2004 | US20040038247 Expression vector comprised of regulatory sequences for lymphocyte specific expression of heterologous polypeptides |
| 02/26/2004 | US20040038245 Diagnosing cell proliferative disorder via identification of gene specific promoter methylation in cells; noninvasive tumor diagnosis |
| 02/26/2004 | US20040038244 Comprises expression vector capable of chromosomal insertion and transcription of telomerase for generating transgenic somatic cells and screening and/or identifying antitumor and anticarcinogenic agents |
| 02/26/2004 | US20040038241 Spatially resolved enzyme-linked assay |
| 02/26/2004 | US20040038240 Method and materials for assessing cancer aggressiveness |
| 02/26/2004 | US20040038237 Pichia pastoris formate dehydrogenase and uses therefor |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038234 Sample generation for genotyping by mass spectrometry |
| 02/26/2004 | US20040038233 An oligonucleotide chip including a species identification probe containing species specific DNA sequence of mycobacterial rpoB gene, a detection probe containing modified codon of rpoB gene, a contrast group probe, a marker |
| 02/26/2004 | US20040038232 Compositions and methods for modulating tumor specific expression |
| 02/26/2004 | US20040038231 Using sequence mismatches and DNA applification to determine statistical correlation between inserted expression vector and phenotypic and/or haplotypes of transformed cells; pharmacogenomics |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038229 Enzymatic manipulation of metal particle-bound DNA |
| 02/26/2004 | US20040038225 Diagnosing, detecting and classifying colon cancer via presence of colon marker polypeptides (COLOUP) |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038221 Test system for detecting a splicing reaction and use therof |
| 02/26/2004 | US20040038220 Methods for categorizing patients |
| 02/26/2004 | US20040038219 Identifying modulators of hepatocyte nuclear factor (HNF4) and treatments for pancreatic disorders |
| 02/26/2004 | US20040038217 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/26/2004 | US20040038215 Oligonucleotide tagged nucleoside triphosphates (OTNTPs) for genetic analysis |
| 02/26/2004 | US20040038213 Genotyping by in situ PCR amplification of a polynucleotide in a tissue biopsy |
| 02/26/2004 | US20040038211 Primer composition and method of using the same in the detection of shigella sonnei |
| 02/26/2004 | US20040038208 Novel human phosphodiesterase IV isozymes |
| 02/26/2004 | US20040038207 Gene expression in bladder tumors |
| 02/26/2004 | US20040038206 Using restriction fragment length polymorphisms to identify gene sequences and diagnose and treat gene disorders |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038201 Diagnostic and therapeutic applications for biomarkers of infection |
| 02/26/2004 | US20040038200 Using monclonal antibodies to differentiate between pathogenic aggregated protein and nonpathogenic, nonaggregated protein molecules; immunoassay |
| 02/26/2004 | US20040038199 Phenotyping assay and reagents therefor |
| 02/26/2004 | US20040038196 Immunoblobulin directed against smallpox inhibitor of complement enzyme (SPICE) for preventing and treating poxviral infections |
| 02/26/2004 | US20040038194 Diagnostic polymerase chain reaction process utilizing simultaneous capture and detection of amplicons |
| 02/26/2004 | US20040037847 Assays for compounds that modulate rhadino virus lana action in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 02/26/2004 | US20040037846 Chlamydia pmp proteins, gene sequences and uses thereof |
| 02/26/2004 | US20040037841 Nucleic acid sequences that are expressed in chondrocytes from fetal, normal, mild osteoarthritic, moderate osteoarthritic, marked and osteoarthritic |
| 02/26/2004 | US20040037837 For stimulating CD8 T-cell response; tuberculosis vaccines; antigen presenting cells |
| 02/26/2004 | US20040037832 Transcription factor as repressor of expression of E-cadherin; detecting galactosidase activity; drug screening |
| 02/26/2004 | US20040037815 Isolation and use of solid tumor stem cells |
| 02/26/2004 | US20040037744 Arrays formed of encoded beads having ligands attached |
| 02/26/2004 | US20040037743 Micropipette and dispenser |
| 02/26/2004 | US20040036870 Method and apparatus for detecting microparticles in fluid samples |
| 02/26/2004 | US20040036085 Functional fluorescence reagent comprising semiconductor nanoparticles |
| 02/26/2004 | US20040035793 For enhancing sensitivity of mutation detection by denaturing high performance liquid chromatography |
| 02/26/2004 | US20040035787 Particulate support for separation/purification or extraction and process of producing the same |
| 02/26/2004 | DE10309368A1 Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase Pharmaceutical preparation containing RNA as a cofactor of hemostasis |
| 02/26/2004 | DE10236711A1 Typing genes that contain polymorphic microsatellite loci, useful for identifying predisposition to disease, by amplification and determining length of amplicons |
| 02/26/2004 | DE10235967A1 Identifying compounds active against non-viral microbes, potentially useful as antibacterial agents, by incubation with eukaryotic cells and the microbe |
| 02/26/2004 | DE10231655A1 Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/26/2004 | DE10145814A1 Verwendung einer Genveränderung im Gen GNB3 kodierend für die β3-Untereinheit menschlicher G-Proteine Use of a gene in the gene GNB3 encoding the β3 subunit of human G-proteins |
| 02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | CA2534394A1 High resolution flow cytometer |
| 02/26/2004 | CA2507486A1 .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom |
| 02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | CA2496155A1 Compositions and methods for inferring ancestry |
| 02/26/2004 | CA2496048A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | CA2495730A1 Avian sex determination method |
| 02/26/2004 | CA2495727A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | CA2495680A1 Hepatitis c viral-like particle purification |
| 02/26/2004 | CA2495643A1 Method and apparatus for washing solid substrate with ultrasonic wave after hybridization reaction |
| 02/26/2004 | CA2495617A1 Determination and/or control of reactor environmental conditions |
| 02/26/2004 | CA2495411A1 Real time measurement of cellular responses |
| 02/26/2004 | CA2495391A1 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | CA2495185A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | CA2495177A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | CA2494847A1 Enos mutants useful for gene therapy |
| 02/26/2004 | CA2494683A1 The use of resveratrol to regulate expression of apolipoprotein a1 |
| 02/26/2004 | CA2494293A1 Treatment of liver deseases |
| 02/26/2004 | CA2493822A1 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | CA2493753A1 Immunostimulatory nucleic acids |
| 02/26/2004 | CA2492932A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/25/2004 | EP1391732A1 Caspase 10 as target for monitoring and treatment of diseases |
| 02/25/2004 | EP1391731A1 Functional fluorescence reagent comprising semiconductor nanoparticles |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1391725A1 Method of identifying phosphoprotein |
| 02/25/2004 | EP1391520A1 Method for preservation of cells and nucleic acid targets |
| 02/25/2004 | EP1391519A1 Nonspecific hybridization inhibitors, clinical examination reagents and clinical examination method |
| 02/25/2004 | EP1391516A1 Von willebrand factor (vwf)-cleaving enzyme |
| 02/25/2004 | EP1391512A1 Polypeptide serving as angiogenic marker and dna thereof |
| 02/25/2004 | EP1391505A1 Stem cells and method of separating the same |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391243A1 Method of cleaning an implement during handling a plurality of samples |
| 02/25/2004 | EP1391242A2 Microcolumn based high throughput microfluidic device |
| 02/25/2004 | EP1391241A1 The use of microfluidic systems in the electrochemical detection of target analytes |
| 02/25/2004 | EP1391205A1 Pharmaceutical composition with RNA as cofactor of hemostasis |
| 02/25/2004 | EP1390896A2 Process for estimating random error in chemical and biological assays |
| 02/25/2004 | EP1390759A2 Assay method for platelet-activating factor |